Advanced Solid Tumors: INCB161734 Treatment

We are testing a new drug for patients with advanced or metastatic solid tumors that have the KRAS G12D mutation. The study aims to understand the safety and dosage of this treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Digestive Oncology
Heverlee, Belgium
Cliniques Universitaires Saint-Luc
Medical Oncology
Sint-Stevens-Woluwe, Belgium
Antwerp University Hospital
Oncology
Wilrijk, Belgium

Sponsor: Incyte Corp.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.